Biogen Idec’s Latest Press Releases

Notice to Readers: Information contained in our press releases should be considered accurate only as of the date of the release. Information in any press release may be superseded by more recent information we have disclosed in later press releases, filings with the Securities and Exchange Commission (“SEC”) or otherwise. Press releases may contain forward-looking statements based on the expectations of our management as of the date of the release. Actual results may materially differ based on several factors, including those described in the press releases and filings with the SEC.

News Archive


Eastern Cooperative Oncology Group (Ecog) Phase III Trial Of Rituxan Maintenance Therapy In Indolent Non-Hodgkin’s Lymphoma Reaches Pre-Specified Efficacy Endpoint Early


Biogen and IDEC Pharmaceuticals Complete Merger to Create New Biotechnology Industry Leader

News Archive